[Treatment of various malignant melanomas of the choroid using a combination of ruthenium 106 and cobalt 60].
The association 106Ru/106Rh and 60Co was used to treat choroidal malignant melanomas with a height of 7 mm above the scleral surface (4 cases) and tumors unsuccessfully treated with a first 60Co plaque therapy (3 cases). The association of both radionuclides allowed a dose of 85 Gy at the apex of the tumor and of 700 Gy at least on the base in every case. All the patients were alive without evidence of metastases with a minimum follow up of one year and the tumor regression was constant and sometimes spectacular.
Bacin
F
F
Clinique ophtalmologique, Centre anticancéreux Jean-Perrin, Centre Hospitalier Régional et Universitaire, Clermont-Ferrand.
Rozan
R
R
Donnarieix
D
D
Dalens
H
H
D000328:Adult; D000368:Aged; D002830:Choroid Neoplasms / Q000532:radiotherapy*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008545:Melanoma / Q000532:radiotherapy*; D008875:Middle Aged; D011879:Radiotherapy Dosage; D012074:Remission Induction; D012429:Ruthenium Radioisotopes / Q000627:therapeutic use*
D003037:Cobalt Radioisotopes; D012429:Ruthenium Radioisotopes
Traitement de certains mélanomes malins de la choroïde par l'association ruthénium 106 et cobalt 60.